Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2024 Sep 20;24(1):1014.
doi: 10.1186/s12879-024-09910-z.

An optimized strategy triggered at the 2nd immunization visit to prevent HIV acquisition by breastfeeding: a phase 2 trial in Burkina Faso (PREVENIR-PEV)

Anaïs Mennecier  1 , Béninwendé Leticia Delphine Sakana  2 , Morgana D'Ottavi  3 , Souleymane Tassembedo  2 , Jean-Pierre Moles  3 , Dramane Kania  2 , Ajani Ousmane Taofiki  4 , Franck Edgar Kadeba  2 , Ibrahima Diallo  2 , Sabrina Eymard-Duvernay  3 , Nicolas Meda  2 , Beatriz Mosqueira  3 , Paulin Fao  2 , Nicolas Nagot  3 ; PREVENIR-PEV Study Group; Philippe Vande Perre  3
Affiliations
Clinical Trial

An optimized strategy triggered at the 2nd immunization visit to prevent HIV acquisition by breastfeeding: a phase 2 trial in Burkina Faso (PREVENIR-PEV)

Anaïs Mennecier et al. BMC Infect Dis. .

Abstract

Background: Mother-to-child transmission of HIV during breastfeeding remains a challenge in low- and middle-income countries (LMIC). A prevention package was initiated during the highly attended 2nd visit of the Expanded Program of Immunisation (EPI-2) to identify the undiagnosed infants living with HIV and reduce the postnatal transmission of infant exposed to HIV.

Methods: PREVENIR-PEV is a non-randomized phase II clinical trial conducted at two health centres in Bobo Dioulasso (Burkina Faso). The study recruited mothers living with HIV aged 15 years and older with their singleton breastfed infants. During EPI-2 (at 8 weeks) and upon signature of the informed consent, a point-of-care early infant diagnosis (EID) was performed. HIV exposed uninfected (HEU) infants were followed-up until 12 months of age. High risk HEU infants (i.e., whose maternal viral load ≥ 1000 cp/mL at EPI-2 or M6) received an extended postnatal prophylaxis (PNP) with lamivudine until end of follow-up or the end of breastfeeding.

Results: Between 4 December 2019 and 4 December 2020, 118 mothers living with HIV-1 were identified, and 102 eligible mother/infant pairs had their infants tested for HIV EID. Six infants were newly diagnosed with HIV, and 96 HEU infants were followed-up for 10 months. Among the participants followed-up, all mothers were prescribed antiretrovirals. All 18 infants eligible for PNP at either EPI-2 or 6 months (M6) were initiated on lamivudine. No HIV transmission occurred, and no serious adverse events were reported in infants receiving lamivudine.

Conclusions: The PREVENIR-PEV prevention package integrated into existing care is safe and its implementation is feasible in a LMIC with a low HIV prevalence. More research is needed to target mother/infant pairs not adhering to the intervention proposed in this trial.

Trial registration: NCT03869944; first registered on 11/03/2019.

Keywords: Africa; Breast feeding; Clinical trial; HIV; Infectious disease transmission; Prevention; Vertical.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
PREVENIR-PEV Study flow diagram. CSPS: Health and Social Promotion Centers (primary care). CMA: level 2 referral health centers. VL: Viral load: cp/mL: copies per mililiter
See this image and copyright information in PMC

References

    1. UNAIDS. The path that ends AIDS_2023 UNAIDS GLOBAL AIDS UPDATE. 2023. Available from: https://thepath.unaids.org/. Cited 2024 Jan 15.
    1. World Health Organization. Guidelines on HIV and infant feeding 2010: principles and recommendations for infant feeding in the context of HIV and a summary of evidence. 2010. 49 p. Available from: https://apps.who.int/iris/handle/10665/44345. Cited 2022 Apr 29. - PubMed
    1. World Health Organization. HIV transmission through breastfeeding : a review of available evidence. 2007 update. 2007. Available from: https://apps.who.int/iris/handle/10665/43879. Cited 2022 Apr 29.
    1. UNICEF, UNAIDS and WHO. Key considerations for programming and prioritization. Going the ‘Last Mile’ to EMTCT: A road map for ending the HIV epidemic in children. UNICEF; 2020. Available from: https://library.unaids.org/?publication=going-the-last-mile-to-emtct-a-r.... Cited 2023 May 12.
    1. Van de Perre P, Goga A, Ngandu N, Nagot N, Moodley D, King R, et al. Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions. Lancet Lond Engl. 2021;397(10281):1316–24. - PubMed

Publication types

Associated data